Related Experiment Video
Updated: May 25, 2026

Quantitating Iron Transport Across the Mouse Placenta In Vivo Using Nonradioactive Iron Isotopes
Published on: May 10, 2022
Zinc protoporphyrin-to-heme ratios in high-risk and preterm infants
Carissa F Cheng1, Joan C Zerzan, Donna B Johnson
1Nutritional Sciences Program, University of Washington, Seattle, WA 98195-6320, USA.
Insights
This study refined reference ranges for zinc protoporphyrin-to-heme ratio (ZnPP/H) in preterm infants. Maternal factors like diabetes influenced ZnPP/H, but iron supplementation changes did not improve levels.
Area of Science:
- Neonatal medicine
- Pediatric hematology
- Biochemistry
Background:
- The zinc protoporphyrin-to-heme ratio (ZnPP/H) is an indicator of iron status.
- Establishing accurate reference ranges for ZnPP/H in preterm infants is crucial for monitoring iron homeostasis.
- Maternal health and iron supplementation protocols can influence neonatal iron status.
Purpose of the Study:
- To establish refined reference ranges for the zinc protoporphyrin-to-heme ratio (ZnPP/H) in preterm infants.
- To investigate the impact of maternal risk factors on neonatal ZnPP/H.
- To evaluate the effect of altered iron supplementation guidelines on infant iron status.
Main Methods:
- Refined neonatal ZnPP/H reference ranges using prospective and retrospective data from infants across various postmenstrual ages (PMA).
- Assessed maternal risk factor impact on ZnPP/H in high-risk infants.
- Retrospectively reviewed serial ZnPP/H data to evaluate changes in iron supplementation protocols.
Main Results:
- Cord ZnPP/H varied significantly with gestational age, being lower at 30-35 weeks' gestation compared to 24-26 weeks.
- Elevated cord ZnPP/H was observed in infants of insulin-dependent diabetic mothers.
- Modifications to iron supplementation protocols did not correlate with improved ZnPP/H measurements.
Conclusions:
- Defined cord blood and postnatal reference ranges for ZnPP/H in preterm infants.
- Neonatal iron balance is influenced by a complex interplay of prenatal and postnatal factors.
- Further research is needed to optimize iron management strategies in preterm neonates.
Objectives:
To refine the reference range for the zinc protoporphyrin-to-heme ratio (ZnPP/H) of preterm infants, we assessed the impact of maternal risk factors on ZnPP/H and evaluated the impact of changes in iron supplementation on iron status.
Study Design:
The reference range for neonatal ZnPP/H was refined using prospective data from 31 reference infants ≤ 35 weeks' postmenstrual age (PMA) plus retrospective data from 51 infants <30 weeks' PMA, and 59 infants 30-40 weeks' PMA. Cord blood and first week of life values were compared when both were available. The impact of maternal risk factors was assessed by examining prospectively collected ZnPP/H from 48 high-risk infants. The effect of changing iron supplementation guidelines was evaluated by retrospective chart review of serial ZnPP/H from 194 infants.
Results:
Cord ZnPP/H was lower at 30-35 weeks' gestation than at 24-26 weeks' gestation (P = .01). Cord ZnPP/H values from insulin-dependent diabetic mothers were elevated compared with reference values. Changing the iron supplementation protocol was not associated with improved ZnPP/H measurements.
Conclusions:
Cord blood and postnatal reference ranges for ZnPP/H are defined. Iron balance depends on a complex interaction of prenatal and postnatal factors.
More Related Videos
Related Concept Videos
Pharmacokinetics in Pediatric Patients: Drug Metabolism
Pharmacokinetics in Pediatric Patients: Drug Distribution

